In this Part 2 review of review atrial fibrillation, we covering direct current cardioversion (DCCV), bleeding and stroke risks, ablation, and left atrial appendage occlusion (LAAO). What are the situations in which CHA2DS2-VASc does not apply? Do you start anticoagulation on a patient who presents with a smartwatch-identified AF with no prior symptoms or diagnosis? How do you decide whether to refer a patient for percutaneous LAA occlusion? What are the success rates and complications of AF ablation? Tune in for answers to these questions.

Difficulty Level: Easy

You are listening to Hu Said: Cardiology Board Review Series (2024-2025 Season)

Please subscribe, rate, and support the channel! Ads help keep materials free for everyone.

More MedEd resources available at ⁠www.rueyhu.com⁠

Updates at Twitter/X: ⁠@Ruey_Hu⁠